Loss of heterozygosity on chromosome arm 11q in lung carcinoids

Human Pathology

Volumn 32, Issue 3, 2001, Pages 333-338

  Petzmann, Susanna ^a   Ullmann, Reinhard ^a   Klemen, Huberta ^a   Renner, Heiko ^a   Popper, Helmut H ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Genetic alterations; Loss of heterozygosity on chromosome 11q; Lung carcinoid; Neuroendocrine lung tumors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CARCINOGENESIS; CARCINOID; CHROMOSOME 11Q; CHROMOSOME MARKER; CLINICAL ARTICLE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG TUMOR; MALE; METASTASIS; MITOSIS; NEUROENDOCRINE TUMOR;

EID: 0035082113     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.22762     Document Type: Article

References (30)

1. Atypical carcinoid tumors of the lung
2. Morphological and immunohistochemical study of typical and atypical carcinoids of the lung with clinico-pathological correlation
3. Reproducibility of neuroendocrine lung tumor classification
4. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11
5. Carcinoid tumors frequenly display genetic abnormalities involving chromosome 11
6. Cytogenetic analysis of six bronchial carcinoids
7. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung
8. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization
9. Genetic changes in the spectrum of neuroendocrine lung tumors
10. Deletion mapping of endocrine tumors localizes a second tumor suppressor gene on chromosome band 11q13
11. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms
12. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions
13. Allelic losses in human chromosome 11 in lung cancer
14. Paragangliomas of the head and neck region show complete loss of heterozygosity at 11q22-q23 in chief cells and the flow-sorted DNA aneuploid fraction
15. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid
16. Clinical features and therapy of typical and atypical bronchial carcinoid tumors (grade 1 and grade 2 neuroendocrine carcinoma)
17. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis
18. Semiautomated assessment of loss of heterozygosity and replication error in tumors
19. Loss of heterozygosity at 11q13: Analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1
20. Unbalanced chromosomal aberrations in neuroendocrine lung tumors as detected by comparative genomic hybridization
21. Reproducibility of neuroendocrine lung tumor classification
22. Differential diagnostic patterns of lung neuroendocrine tumors
23. Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription
24. Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer
25. Association of CD44 with OTS-8 in tumor vascular endothelial cells
26. Stromal fibroblasts adjacent to invasive thyroid tumors: Expression of gelatinase A but not stromelysin 3 mRNA
27. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas
28. Nonrandom structural and numerical chromosome changes in non-small-cell lung cancer
29. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice